Page last updated: 2024-11-02

phenobarbital and CKD-MBD

phenobarbital has been researched along with CKD-MBD in 2 studies

Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.

Research Excerpts

ExcerptRelevanceReference
"Three children with azotaemic renal osteodystrophy were treated with 1,25-dihydroxycholecalciferol (1,25(OH)2D3)."1.261,25-dihydroxycholecalciferol in renal osteodystrophy. Epiphysiolysis--anticonvulsant therapy. ( Dellagrammatikas, H; Ellis, HA; Norman, AW; Pierides, AM; Scott, JE, 1977)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DUNDAS, JB1
Pierides, AM1
Ellis, HA1
Dellagrammatikas, H1
Scott, JE1
Norman, AW1

Other Studies

2 other studies available for phenobarbital and CKD-MBD

ArticleYear
LOWE'S SYNDROME.
    Proceedings of the Royal Society of Medicine, 1964, Volume: 57

    Topics: Acidosis; Albuminuria; Alkalies; Anti-Bacterial Agents; Blood; Bone Diseases; Calcium; Cataract; Chi

1964
1,25-dihydroxycholecalciferol in renal osteodystrophy. Epiphysiolysis--anticonvulsant therapy.
    Archives of disease in childhood, 1977, Volume: 52, Issue:6

    Topics: Adolescent; Bone and Bones; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Dihy

1977